Écrit par PRNewswire | 01 Février 2017

SEATTLE, Jan. 31, 2017 - ReachBio Research Labs (trade name under Reachbio LLC®) has announced the launch of their new drug development platform, cellPrism®. The platform is designed to offer biotechnology and pharmaceutical companies a spectrum of customized in vitro assays to assess and evaluate potential program challenges that may arise during the drug development process.

The...

Écrit par Rare Genomics Institute | 01 Février 2017

Los Angeles, C.A. January 31, 2017. Rare Genomics Institute (RG) and the Organization for Rare Diseases India (ORDI) announced today that they are one of the recipients of Sanofi Genzyme’s 6th annual Patient Advocacy Leadership (PAL) Awards for 2016. RG and ORDI have won financial support for the development and dissemination of specialized Rare Disease online training modules.

The...

Écrit par WHO | 01 Février 2017

It includes 10 commitments, including increasing vaccine-related funding, strengthening supply chains and delivery systems, and making universal access to vaccines a cornerstone of health and development efforts

ADDIS ABABA, Ethiopia, January 31, 2017/ -- Today, Heads of State from across Africa adopted a Declaration on Universal Access to Immunization in Africa, in which they endorsed Addis...

Écrit par Chaire UNESCO Santé sexuelle & Droits humains | 01 Février 2017

La Chaire UNESCO Santé sexuelle & Droits humains, dans le cadre du nouveau du Pôle universitaire Paris Diderot « Santé sexuelle, Sexologie et Droits humains » a le plaisir de vous présenter l'ouverture au public d'un cycle de conférences transdisciplinaires intitulé "Santé sexuelle pour tous".
Lancement d'un cycle de 7 conférences transdisciplinaires "Santé sexuelle pour tous"...